Lecap Asset Management Ltd
Source: SEC Form 13F · as of Mar 2026Lecap Asset Management Ltd holds 18 biotech & pharma companies tracked by BioSniper, totaling $15.8M in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$15.8M
| Company | Shares | Value |
|---|---|---|
| ELVElevance Health Inc. | 6,383 | $1.9M |
| DVADaVita Inc. | 8,417 | $1.3M |
| MEDPMedpace Holdings Inc. | 2,547 | $1.2M |
| GMOptec International, Inc. | 16,383 | $1.2M |
| VTRSViatris Inc | 88,141 | $1.2M |
| ABTABBOTT LABORATORIES | 9,143 | $939K |
| LLYELI LILLY & Co | 1,019 | $937K |
| QGENQIAGEN N.V. | 21,958 | $879K |
| INSPInspire Medical Systems Inc. | 15,605 | $805K |
| WSTWest Pharmaceutical Services Inc. | 3,121 | $782K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 1,507 | $673K |
| GILDGILEAD SCIENCES, INC. | 4,755 | $663K |
| MRKMerck & Co., Inc. | 5,352 | $644K |
| REGNREGENERON PHARMACEUTICALS, INC. | 816 | $630K |
| UTHRUNITED THERAPEUTICS Corp | 969 | $575K |
| CAHCardinal Health Inc. | 2,590 | $547K |
| HALOHALOZYME THERAPEUTICS, INC. | 7,349 | $475K |
| MCKMcKesson Corporation | 501 | $434K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.